Asthma and COPD: two sides of bronchial inflammation
Asthma (600,000 people in Belgium): eosinophilic Th2-mediated inflammation (IL-4, IL-5, IL-13), bronchial hyperreactivity, reversible obstruction.
COPD (300,000 in Belgium): neutrophilic inflammation (IL-8, TNF-α, NF-κB), emphysematous destruction, irreversible obstruction.
Ginger acts on both pathologies through distinct but partially overlapping mechanisms.
Ginger mechanisms in the airways
| Pathology/symptom | Mechanism | Ginger target | Expected effect |
|---|---|---|---|
| Allergic asthma | Th2 → IL-5, IL-13 → eosinophils | NF-κB ↓ → IL-5, eotaxin ↓ | ↓ bronchial eosinophils |
| COPD/emphysema | NF-κB → IL-8, MMP-9 → destruction | NF-κB ↓ → IL-8, MMP-9 ↓ | ↓ alveolar destruction |
| Excess mucus | IL-13/NF-κB → MUC5AC ↑ | MUC5AC ↓ indirect | ↓ mucus obstruction |
| Bronchospasm | PDE → cAMP ↓ → contraction | PDE ↓ → cAMP ↑ → relaxation | ↑ airway diameter |
| Chronic cough | TRPV1 → Substance P | TRPV1 desensitization | ↓ neurogenic cough |
| Pollution/smoking | ROS → NF-κB bronchial | Nrf2 → HO-1 → ROS ↓ | ↓ inflammatory response |
NF-κB inhibition in bronchial epithelial cells
Asthma: NF-κB → IL-5 (eosinophil survival), IL-13 (mucus, hyperreactivity), eotaxin (eosinophil recruitment). Ginger inhibits NF-κB → ↓ Th2 inflammation.
COPD: NF-κB → IL-8 (neutrophil recruitment), TNF-α, MMP-9 (alveolar destruction). Ginger inhibits NF-κB → ↓ neutrophils → ↓ emphysematous destruction.
Reduced mucus production (MUC5AC)
MUC5AC is the primary bronchial mucus glycoprotein — overproduced in asthma and bronchitis. IL-13 and NF-κB stimulate MUC5AC in goblet cells. Ginger inhibits this expression → ↓ mucus hypersecretion → less obstructed airways → ↑ mucociliary clearance.
Phosphodiesterase inhibition (bronchodilation)
PDE degrades cAMP (second messenger that relaxes airway smooth muscle). PDE inhibitors (theophylline, roflumilast) are bronchodilators. Ginger inhibits certain PDE isoforms → ↑ intracellular cAMP → airway smooth muscle relaxation → ↑ airway diameter → ↓ dyspnea.
TRPV1 desensitization (neurogenic cough)
Chronic cough and bronchial hyperreactivity involve hyperactivation of sensory C-fibers via TRPV1 → Substance P and CGRP release → neurogenic bronchial inflammation. Ginger desensitizes TRPV1 → ↓ Substance P → ↓ neurogenic cough.
❓ FAQ — Ginger and airways
Q: Can ginger replace bronchodilators or inhaled steroids?
A: No. β2-agonists and inhaled steroids are indispensable in moderate to severe asthma. Ginger can supplement treatment (inflammation, mucus) but does not replace prescribed treatments. Consult your pulmonologist.
Q: Does ginger help with dry irritative cough?
A: Yes — dry neurogenic cough involves TRPV1 (which ginger desensitizes). Productive cough (with mucus) also improves via ↓ MUC5AC. Effectiveness varies by etiology.
Q: Does GIMBER sugar worsen asthma?
A: Potentially. Sugar → NF-κB → IL-5, IL-13 → exacerbation of bronchial eosinophilia. Obesity due to sugar also worsens asthma (↑ diaphragmatic pressure, ↑ adipokine-inflammation).
Related articles
Further reading on related topics :
- Ginger and multiple sclerosis: myelination, neuroinflammation and Th17/Treg central — BDNF and NF-κB — INTI
- Ginger and tendonitis, bursitis and plantar fasciitis: COX-2, VEGF tendon and NF-κB — sports protocol — INTI
- Ginger and cellular aging: SASP, senescence, telomeres and NAD+/SIRT1 — INTI
- Ginger and dental health: periodontitis, gingivitis and caries — NF-κB gingival, P.gingivalis and RANKL alveolar — INTI
- Ginger and depression: MAO-A/B, BDNF/TrkB, HPA axis and neuroplasticity — INTI
- hashimoto-hypothyreoidie-knobbels-nf-kb-th17-treg-tpo-nrf2-inti">Ginger and thyroid: thyroide-hashimoto-hypothyroidie">ginger Hashimoto, hypothyroidism and nodules — NF-κB, Th17/Treg and TPO — INTI
- Ginger and kidney health: nephroprotection, glomerular filtration and renal NF-κB — INTI
- fibromyalgia-lagerugpijn-artrose-nsaid-inti">Ginger and chronic pain: integrative guide (fibromyalgia, lower back pain, ginger osteoarthritis) — INTI vs NSAIDs